title: An adenosine A2a agonist increases sleep and induces Fos in ventrolateral preoptic neurons.
abstract: Considerable evidence indicates that adenosine may be an endogenous somnogen, yet the mechanism through which it promotes sleep is unknown. Adenosine may act via A1 receptors to promote sleep, but an A2a receptor antagonist can block the sleep induced by prostaglandin D(2). We previously reported that prostaglandin D(2) activates sleep-promoting neurons of the ventrolateral preoptic area, and we hypothesized that an A2a receptor agonist also should activate these neurons. Rats were instrumented for sleep recordings, and an injection cannula was placed in the subarachnoid space just anterior to the ventrolateral preoptic area. After an 8-10-day recovery period, the A2a receptor agonist CGS21680 (20 pmol/min) or saline was infused through the injection cannula, and the animals were killed 2 h later. The brains were stained using Fos immunohistochemistry, and the pattern of Fos expression was studied in the entire brain. CGS21680 increased non-rapid eye movement sleep and markedly increased the expression of Fos in the ventrolateral preoptic area and basal leptomeninges, but it reduced Fos expression in wake-active brain regions such as the tuberomammillary nucleus. CGS21680 also induced Fos in the shell and core of the nucleus accumbens and in the lateral subdivision of the central nucleus of the amygdala. To determine whether these effects may have been mediated through A1 receptors, an additional group of rats received subarachnoid infusion of the A1 receptor agonist N(6)-cyclopentyladenosine (2 pmol/min). In contrast to CGS21680, infusion of N(6)-cyclopentyladenosine into the subarachnoid space produced only a small decrease in rapid eye movement sleep, and the pattern of Fos expression induced by N(6)-cyclopentyladenosine was notable only for decreased Fos in regions near the infusion site. These findings suggest that an adenosine A2a receptor agonist may activate cells of the leptomeninges or nucleus accumbens that increase the activity of ventrolateral preoptic area neurons. These ventrolateral preoptic area neurons may then coordinate the inhibition of multiple wake-promoting regions, resulting in sleep.
authors.affiliation: Department of Neurology, Beth Israel Deaconess Medical Center, Boston, MA 02115, USA. tscammel@caregroup.harvard.edu
authors.forename: T E
authors.initials: TE
authors.lastname: Scammell
authors.forename: D Y
authors.initials: DY
authors.lastname: Gerashchenko
authors.forename: T
authors.initials: T
authors.lastname: Mochizuki
authors.forename: M T
authors.initials: MT
authors.lastname: McCarthy
authors.forename: I V
authors.initials: IV
authors.lastname: Estabrooke
authors.forename: C A
authors.initials: CA
authors.lastname: Sears
authors.forename: C B
authors.initials: CB
authors.lastname: Saper
authors.forename: Y
authors.initials: Y
authors.lastname: Urade
authors.forename: O
authors.initials: O
authors.lastname: Hayaishi
mesh_terms: D000241:Adenosine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000959:Antihypertensive Agents / Q000494:pharmacology; D001923:Brain Chemistry / Q000187:drug effects; D008297:Male; D009474:Neurons / Q000737:chemistry / Q000378:metabolism*; D010627:Phenethylamines / Q000494:pharmacology; D011301:Preoptic Area / Q000166:cytology* / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000032:analysis / Q000096:biosynthesis*; D058906:Purinergic P1 Receptor Agonists; D051381:Rats; D017207:Rats, Sprague-Dawley; D043705:Receptor, Adenosine A2A; D012890:Sleep / Q000187:drug effects*; D013047:Specific Pathogen-Free Organisms; D013346:Subarachnoid Space; D014851:Wakefulness / Q000187:drug effects
chemical_list: D000959:Antihypertensive Agents; D010627:Phenethylamines; D016760:Proto-Oncogene Proteins c-fos; D058906:Purinergic P1 Receptor Agonists; D043705:Receptor, Adenosine A2A; C061282:2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine; C048599:N(6)-cyclopentyladenosine; D000241:Adenosine